Healthcare (Substance Abuse)

LD 1530 requires Maine insurance companies to pay ambulance and nontransporting emergency medical services (EMS) providers specific reimbursement rates, including 200% of Medicare rates for in-network providers and 180% for out-of-network providers, with extra payments for rural areas. It prohibits insurers from requiring prior authorization for most ambulance transports to hospitals or facilities (like nursing homes) and ensures on-scene care - such as administering naloxone for opioid overdoses without transport - is reimbursed. The bill also limits annual rate increases for providers with rates below 200% of Medicare to 5% and clarifies that community paramedicine services may still require prior authorization. This directly affects EMS providers, rural communities, and patients receiving emergency care in Maine.

This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.

This bill prohibits MaineCare (Maine's Medicaid program) from restricting coverage for individuals with opioid use disorder who need both methadone maintenance treatment and concurrent intensive outpatient programs or other outpatient services for substance use or behavioral health disorders. It directly affects MaineCare enrollees seeking integrated treatment for opioid addiction, removing barriers to receiving both medication-based care and counseling services simultaneously. The key provision requires the Department of Health and Human Services to adopt implementing rules within 90 days to ensure coverage is not denied or restricted for these concurrent services. The bill mandates that coverage must be provided for medically appropriate combinations of methadone treatment and outpatient programs without prior authorization hurdles.

This resolution provides $1 million annually for two years to support Maine's five certified community behavioral health clinics participating in a federal Medicaid program. It directly affects these clinics by funding critical staff hiring and wage increases for clinical positions (raising wages to 125% of the state median wage) and administrative roles (to 100% of median wage). The funding specifically enhances the state's clinic rate methodology to improve access to mental health and substance use disorder services in local communities. The resolution was enacted as an emergency to meet a federal program deadline before the 90-day legislative window expired.

LD 189 removes the requirement for health care facilities to obtain state approval (a "certificate of need") before offering mental health services or substance use disorder treatment in Maine. This change directly affects facilities providing these services, allowing them to expand or start new programs without waiting for state review. By eliminating this regulatory barrier, the bill aims to increase the availability and affordability of mental health and substance use disorder care for residents. The legislation amends Maine law to specifically exclude these services from the certificate of need process.